Summary

Company announcement date:
FDA Publication Date:
Kind of product:
medicines

Reason for posting:

A description of the reason for the call

Contains tadalafil

Company name:
Loud Muscle Science, LLC
Brand Name:
Description of the product:

Description of the product

Launch Sequence Aphrodisia and Euphoria capsules


Company message

FOR IMMEDIATE RELEASE – 6/27/22 – Hauppauge, NY, Loud Muscle Science, LLC is voluntarily recalling the following Launch Sequence products and batches listed in the table below at the consumer level. Laboratory analysis performed at the request of Loud Muscle Science, LLC found that the products were contaminated with tadalafil, an ingredient in FDA-approved male erectile dysfunction treatment products in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. The presence of tadalafil in Launch Sequence products makes these products unapproved drugs for which safety and efficacy have not been established and are therefore subject to recall.

Risk Statement: The most critical potential adverse health consequence of inadvertent consumption of product contaminated with undeclared tadalafil is profound, life-threatening hypotension associated with drug interactions with nitroglycerin or guanylate cyclase inhibitors. In the intended use population, profound hypotension may lead to heart attack, stroke, or death. To date, Loud Muscle Science has not received any reports of adverse events related to this recall.

These tainted Launch Sequence Capsule products are marketed as nutritional supplements for male sexual enhancement. Affected products and batches are:

Product packet size Container type ASIN UPC code many # Expiry date
Release consecutive capsules 60 A bottle B07TLPWXDS 641378938375 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025
Run Sequence Euphoria Capsules 10 Tin B08ZJX4V9J 661020846864 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025
Run Sequence Aphrodisia Capsules 4 Tin B07QB3S2LV 661020846957 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025
Release consecutive capsules 60 A bottle B08HM7VHCX 661020848166 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025
Run Sequence Euphoria Capsules 10 Tin B08ZJX4V9J 661020846864 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025
Run Sequence Aphrodisia Capsules 4 Tin B09S12VK3F 661020846957 C07172101 07/2024
2022054 03/2025
2021001 12/2024
2022104 04/2025

Launce Sequence capsule products are sold under Amazon ASIN numbers B07TLPWXDS (US 60 count) and B08HM7VHCX (Canada 60 count); Launch Sequence Euphoria capsule products are sold under Amazon ASIN numbers B08ZJX4V9J (Euphoria USA 10 count) and B08ZJX4V9J (Euphoria Canada 10 count); and Launch Sequence Aphrodisia capsules are sold under Amazon ASIN numbers B07QB3S2LV (Aphrodisia USA 4 count) and B09S12VK3F (Aphrodisia Canada 4 count). The products can be identified by the labels and packaging below. The product was marketed via the Internet and fulfilled by Amazon at www.amazon.com Nationwide in the US and www.amazon.ca in Canada, on eBay.com and in retail stores.

Loud Muscle Science is notifying its distributors and customers by letter and this press release and is providing refunds to its customers. Users who have the Launch Sequence products should stop using the product and dispose of it.

Consumers with questions about this recall may contact Loud Muscle Science, LLC at phone number: 631-270-4188 or email at [email protected] — Monday through Friday 9am – 4am EST. Users should contact their physician or health care provider if they have experienced problems that may be related to the intake or use of this medicinal product.

Adverse reactions or quality problems that occur with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting Program online, by regular mail, or by fax.

This recall is being made with the knowledge of the US Food and Drug Administration.


Company contact information